For: | Greco G, Cascella T, Facciorusso A, Nani R, Lanocita R, Morosi C, Vaiani M, Calareso G, Greco FG, Ragnanese A, Bongini MA, Marchianò AV, Mazzaferro V, Spreafico C. Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma. World J Radiol 2017; 9(5): 245-252 [PMID: 28634515 DOI: 10.4329/wjr.v9.i5.245] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i5/245.htm |
Number | Citing Articles |
1 |
Degang Kong, Tao Jiang, Jian Liu, Xinyi Jiang, Bei Liu, Cheng Lou, Baobing Zhao, Steven L. Carroll, Gong Feng. Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal. Drug Delivery 2020; 27(1): 1729 doi: 10.1080/10717544.2020.1856219
|
2 |
Su Min Cho, Hee Ho Chu, Jong Woo Kim, Jin Hyung Kim, Dong Il Gwon. Initial Transarterial Chemoembolization (TACE) Using HepaSpheres 20–40 µm and Subsequent Lipiodol TACE in Patients with Hepatocellular Carcinoma > 5 cm. Life 2021; 11(4): 358 doi: 10.3390/life11040358
|
3 |
Jose Urbano, J. Javier Echevarria-Uraga, J. Jose Ciampi-Dopazo, Juan A. Sánchez-Corral, Jorge Cobos Alonso, Ane Anton-Ladislao, Borja Peña-Baranda, Veronica Nacarino-Mejias, Rocío González-Costero, J. Joaquín Muñoz Ruiz-Canela, Julian Pérez-Cuesta, Carlos Lanciego, Miguel Angel de Gregorio. Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma. European Journal of Radiology 2020; 126: 108966 doi: 10.1016/j.ejrad.2020.108966
|
4 |
Luc Defreyne. Interventional radiology for liver diseases. European Radiology 2021; 31(4): 2227 doi: 10.1007/s00330-020-07356-w
|
5 |
Guorong Jia, Juno Van Valkenburgh, Austin Z. Chen, Quan Chen, Jindian Li, Changjing Zuo, Kai Chen. Recent advances and applications of microspheres and nanoparticles in transarterial chemoembolization for hepatocellular carcinoma. WIREs Nanomedicine and Nanobiotechnology 2022; 14(2) doi: 10.1002/wnan.1749
|
6 |
Yang Jun Kang, Byung Chan Lee, Jae Kyu Kim, Nam Yeol Yim, Hyoung Ook Kim, Soo Buem Cho, Yong Yeon Jeong. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma. CardioVascular and Interventional Radiology 2020; 43(1): 55 doi: 10.1007/s00270-019-02349-9
|
7 |
Andrea C Cortes, Hideyuki Nishiofuku, Urszula Polak, Adeeb A Minhaj, Mirtha S Lopez, Kimihiko Kichikawa, Aliya Qayyum, Elizabeth M. Whitley, Rony Avritscher. Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma. Nanomedicine: Nanotechnology, Biology and Medicine 2022; 39: 102465 doi: 10.1016/j.nano.2021.102465
|
8 |
Giovanni Mauri, Gianluca Maria Varano, Paolo Della Vigna, Guido Bonomo, Lorenzo Monfardini, Maria Giulia Zampino, Paola Simona Ravenda, Franco Orsi. Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study. CardioVascular and Interventional Radiology 2018; 41(11): 1708 doi: 10.1007/s00270-018-2017-x
|
9 |
Matthew L. Hung, Jerry Jiang, Harry Trieu, Frank Hao, Navid Eghbalieh, Peng-Xu Ding, Edward Wolfgang Lee. Transarterial Chemoembolization of Hepatocellular Carcinoma with Oncozene Microspheres: An Initial, Short-Term Clinical Experience—A Retrospective, Matched, Comparison Study. Life 2021; 11(7): 600 doi: 10.3390/life11070600
|
10 |
Michael Wholey, Raul Palacios III, Daniel Wholey, Alejandro Mendez. Safety and Long-Term Survival Outcome in Patients With Unresectable Barcelona Clinic Liver Cancer (BCLC) Stages C and D Advanced Hepatocellular Carcinoma Treated With 40 μm Drug-Eluting Bead Transcatheter Arterial Chemoembolization. Cureus 2022; doi: 10.7759/cureus.24047
|
11 |
Lynn Jeanette Savic, Evan Chen, Nariman Nezami, Nikitha Murali, Charlie Alexander Hamm, Clinton Wang, MingDe Lin, Todd Schlachter, Kelvin Hong, Christos Georgiades, Julius Chapiro, Fabian M. Laage Gaupp. Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety. Cancers 2022; 14(23): 5847 doi: 10.3390/cancers14235847
|
12 |
Katharina Carolin Albrecht, René Aschenbach, Ioannis Diamantis, Niklas Eckardt, Ulf Teichgräber. Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres. Journal of Cancer Research and Clinical Oncology 2021; 147(1): 23 doi: 10.1007/s00432-020-03370-z
|
13 |
Nur Aisyah Nuzulia, Terry Mart, Ifty Ahmed, Yessie Widya Sari. The Use of Microspheres for Cancer Embolization Therapy: Recent Advancements and Prospective. ACS Biomaterials Science & Engineering 2024; 10(2): 637 doi: 10.1021/acsbiomaterials.3c00659
|
14 |
Antonio Facciorusso. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World Journal of Gastroenterology 2018; 24(2): 161-169 doi: 10.3748/wjg.v24.i2.161
|
15 |
Chia-Ying Lin, Yi-Sheng Liu, Kuang-Tse Pan, Chia-Bang Chen, Chein-Fu Hung, Chen-Te Chou. The short-term safety and efficacy of TANDEM microspheres of various sizes and doxorubicin loading concentrations for hepatocellular carcinoma treatment. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91021-9
|
16 |
Pierleone Lucatelli, Marta Burrel, Boris Guiu, Gianluca de Rubeis, Otto van Delden, Thomas Helmberger. CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation. CardioVascular and Interventional Radiology 2021; 44(12): 1851 doi: 10.1007/s00270-021-02968-1
|
17 |
Fabio Melchiorre, Francesca Patella, Lorenzo Pescatori, Filippo Pesapane, Enrico Fumarola, Pierpaolo Biondetti, Pietro Brambillasca, Cristian Monaco, Anna Maria Ierardi, Giuseppe Franceschelli, Gianpaolo Carrafiello. DEB-TACE: A Standard Review. Future Oncology 2018; 14(28): 2969 doi: 10.2217/fon-2018-0136
|
18 |
Zhanguo Sun, Dechao Jiao, Yi Fang, Yiming Liu, Kaihao Xu, Chengzhi Zhang, Yuanhao Huang, Xinwei Han. Efficacy and safety of raltitrexed-eluting CalliSpheres® bead transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma: a single-arm, prospective study. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241229661
|
19 |
Huseyin Balli, Erol Aksungur, Behruz Khalatai, Kairgeldy Aikimbaev. Super-Selective Transarterial Chemoembolization with Doxorubicin-Loaded Drug-Eluting Beads Sized Below and Above 100 Microns in Hepatocellular Carcinoma: A Comparative Study. Journal of the Belgian Society of Radiology 2019; 103(1) doi: 10.5334/jbsr.1841
|
20 |
Huseyin Tugsan Balli, Kairgeldy Aikimbaev. Liver Cancer in the Middle East. 2021; : 171 doi: 10.1007/978-3-030-78737-0_10
|
21 |
Julien Delicque, Boris Guiu, Mathieu Boulin, Heidi Schwanz, Lauranne Piron, Christophe Cassinotto.
Liver Chemoembolization of Hepatocellular Carcinoma using TANDEM
®
Microspheres
. Future Oncology 2018; 14(26): 2761 doi: 10.2217/fon-2018-0237
|
22 |
Hai-Dong Zhu, Xiao Li, Jun-Hui Sun, Xu Zhu, Zhao-Yu Liu, Hai-Liang Li, Jian Lu, Zhi-Ping Yan, Guo-Liang Shao, Xiao-Feng He, Min Chao, Li-Gong Lu, Bin-Yan Zhong, Rui Li, Qi Zhang, Gao-Jun Teng. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial). CardioVascular and Interventional Radiology 2024; 47(3): 325 doi: 10.1007/s00270-024-03666-4
|
23 |
Tommaso Cascella, Enrico Matteo Garanzini, Rodolfo Lanocita, Carlo Morosi, Federica Riva, Giorgio Greco, Carlo Sposito, Vincenzo Mazzaferro, Alfonso Marchianò, Carlo Spreafico. Long Term Survival Analysis in a Cohort of 125 Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using Small Drug Eluting Beads. CardioVascular and Interventional Radiology 2022; 45(1): 54 doi: 10.1007/s00270-021-02991-2
|